Belief in providing better diagnostic solutions inspired the founders of Serosep to form the company in 1997, beginning initially with the distribution of carefully selected diagnostics products for Clinical Microbiology, Histopathology and Environmental Laboratories.
Maintaining continuous critical analysis of the best diagnostic solutions available led Serosep to accumulate vast market knowledge. A combination of this knowledge with years of distribution experience to clinical laboratories, enabled us to understand & appreciate the daily challenges faced by laboratory staff. This passion for excellence and dedication to customer care in distribution allowed Serosep to develop new and exciting opportunities.
Twenty five years on, Serosep continue to improve the quality of patient results and the daily lives of scientists by offering easy to use diagnostic solutions. Serosep is a thriving company with over 120 employees between the head office in Limerick and its UK office. Continuous investment in R&D facilities, commitment to innovation and product development, places Serosep at the forefront of the diagnostic solution market. Serosep now export its product range across five continents with impressive sales in over 35 countries worldwide.
In 2021, Serosep were delighted to be awarded Medtech company of the year. According to Dermot Scanlon, CEO & founder of Serosep Ltd, “Winning this award is testimony to the hard work, commitment, and dedication of all our employees. We believe this award will motivate us all to continue forging ahead, achieving bigger and better things. We are deeply humbled, honoured and profoundly grateful to accept this award.”
Serosep Limited is founded in Limerick, Ireland
Began life as distributor of laboratory diagnostic products.
Began manufacture of HistoPot , Biopsy Fixation Solutions for Histopathology.
Launched Precision water chemistry reagents.
EntericBio Strip based faecal/stool pathogen kit is launched, a 24 hour test.
Fully automated production line is installed for high volume production of HistoPot to cope with increased demand for the product.
OcFfirst EntericBio realtime Gastro Panel 1 diagnostic kit. The new improved test provided results within 3hrs v 24hrs using the older EntericBio strip based assay.
This year saw the beginning of Serosep UK Ltd, a fully owned subsidiary based in West Sussex, UK.
EntericBio becomes routinely used in many clinical microbiology laboratories throughout Ireland. 75% of samples are tested using EntericBio in Ireland.
Serosep Ltd launch HistoPot Mini.
EntericBio gains market entry into the UK. EntericBio Gastro Panel 2 real time diagnostic kit launched. EntericBio award major UK contracts with NHS Hospitals.
An estimated 85% of clinical microbiology laboratories in Ireland now using EntericBio real time assay Gastro Panel 2 and EntericBio C. Difficile in routine use.
EntericBio becomes routinely used in Holland and New Zealand laboratories.
Building work commences for new state of the art laboratories at Serosep Ltd. R&D begins for the development of the next panel for EntericBio Realtime Gastro Panel 3.
Awarded Public Health Wales tender for Molecular Enteric Pathogen Testing.
Serosep Wins Best SME Employer at the Family friendly awards.
Serosep and Quidel partner to supply EntericBio Dx in US.
EntericBio Dx Molecular GI panel is cleared by FDA.
Serosep react quickly to the Covid-19 pandemic with the introduction of RespiBio
Registration of Histopot® in Russia
Letterkenny University Hospital goes live with RespiBio®
UHL goes live with CPE screening
Additional panels added to RespiBio® product range – Flu A/B & RSV
Awarded Medtech Company of the Year
PathCare in South Africa become 52nd EntericBio® Site
Serosep become a member of the British In Vitro Diagnostics Association (BIVDA)
The SFI Research Centre for Pharmaceuticals and Serosep partner to improve time on Bacterial & Viral test kits
The Royal Cornwall Hospital in Wales becomes EntericBio® 50th Customer
Serosep celebrate 25 years in business
Certified by employees as “A Great Place to Work”
RESPIBIO® Covid-19 Test Kits Receive UK Validation
Serosep & Dynex Partner to install the Agility ELISA system to Dublin Hospital
Over twenty years ago, we established Serosep with the aim of providing better diagnostic solutions for Clinical Microbiology, Histopathology and Environmental Laboratories. This vision continues to our ever-growing team with a constant and total focus on pushing back the boundaries of what is both available and achievable provides the platform for our research, development and innovation activities.
We leave no stone unturned, integrating future proofed responsiveness and scientific experience and learning as a lasting legacy into our processes, our products, our support services an into our wider community.